reglab/statecodes huggingface dataset:
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 51 - FORENSIC LABORATORIES › Chapter 10.51.06 - Employees › Section 10.51.06.06 - Director - General Duties and Responsibilities

Current through Register Vol. 51, No. 14, July 12, 2024
A. A director of a forensic laboratory is
				  responsible for the overall operation and administration of the forensic
				  laboratory.
B. A director of a
				  forensic laboratory shall participate in and actively oversee the planning,
				  organization, direction, and review of all laboratory operations, including but
				  not limited to:
(1) Employing individuals who
				  are competent to:
(a) Perform a forensic
				  analysis; and
(b) Record and report
				  a forensic analysis:
(i) Promptly within the
				  priority protocols established by the director;
(ii) Accurately; and
(iii) Proficiently; and
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 51 - FORENSIC LABORATORIES › Chapter 10.51.06 - Employees › Section 10.51.06.08 - Quality Assurance Manager - Requirements

Current through Register Vol. 51, No. 14, July 12, 2024
A. A director of a forensic laboratory shall
				  designate a qualified individual as a quality assurance manager to be
				  responsible for coordinating the activities required to ensure quality forensic
				  analysis services.
B. A quality
				  assurance manager may be employed full-time or part-time as appropriate for the
				  scope of forensic analysis services offered or performed.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 51 - FORENSIC LABORATORIES › Chapter 10.51.06 - Employees › Section 10.51.06.09 - Quality Assurance Manager - Qualifications

Current through Register Vol. 51, No. 14, July 12, 2024
A quality assurance manager of a forensic laboratory
					 shall:
A. Hold an earned baccalaureate
				  or advanced degree from an accredited institution in:
(1) Forensic science;
(2) A natural science such as:
(a) Chemistry;
(b) Physics; or
(c) Biology; or
(3) A subspecialty of a natural science such
				  as:
(a) Organic chemistry;
(b) Biochemistry; or
(c) Molecular biology; and
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 51 - FORENSIC LABORATORIES › Chapter 10.51.06 - Employees › Section 10.51.06.10 - Quality Assurance Manager - Duties and Responsibilities

Current through Register Vol. 51, No. 14, July 12, 2024
A. Under the
				  authority of the director, and operating independently of casework, a quality
				  assurance manager shall be responsible for:
(1) Establishing:
(a) A comprehensive quality assessment system
				  that includes quality control and quality assessment programs that cover the
				  forensic analyses performed; and
(b) Parameters for necessary levels of
				  performance for forensic analyses;
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 51 - FORENSIC LABORATORIES › Chapter 10.51.06 - Employees › Section 10.51.06.11 - Technical Leader - Requirements

Current through Register Vol. 51, No. 14, July 12, 2024
A. If a licensee performs or offers to
				  perform forensic analyses in the discipline of Biology-DNA analysis, a forensic
				  laboratory shall have a technical leader who:
(1) Meets the qualifications set forth in
				  this chapter; and
(2) Is
				  responsible for the technical and scientific oversight of the section or unit
				  in a forensic laboratory that performs forensic analyses for DNA.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 51 - FORENSIC LABORATORIES › Chapter 10.51.06 - Employees › Section 10.51.06.12 - Technical Leader - Qualifications

Current through Register Vol. 51, No. 14, July 12, 2024
A. General. Except for the discipline of
				  Biology-DNA analysis, a technical leader in a discipline or subdiscipline of a
				  forensic laboratory shall:
(1) Hold an earned
				  baccalaureate or advanced degree from an accredited institution in:
(a) Forensic science;
(b) A natural science such as:
(i) Chemistry;
(ii) Physics; or
(iii) Biology; or
(c) A subspecialty of a natural science such
				  as:
(i) Organic chemistry;
(ii) Biochemistry; or
(iii) Molecular biology; and
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 51 - FORENSIC LABORATORIES › Chapter 10.51.06 - Employees › Section 10.51.06.13 - Technical Leader - Responsibilities

Current through Register Vol. 51, No. 14, July 12, 2024
A. Authority. A licensee may authorize a
				  technical leader to initiate, suspend, and resume a forensic analysis or
				  forensic analyses operations for:
(1) The
				  laboratory, if assigned to the technical leader;
(2) The forensic analysis section or unit of
				  the laboratory assigned to the technical leader; or
(3) An individual in the technical leader's
				  assigned forensic analysis section or unit of the laboratory.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 51 - FORENSIC LABORATORIES › Chapter 10.51.06 - Employees › Section 10.51.06.14 - Forensic Analysis Employees - Requirement

Current through Register Vol. 51, No. 14, July 12, 2024
A licensee shall ensure:
A. The forensic laboratory has at least one
				  individual who meets the employee qualification requirements of this chapter,
				  to perform the functions set forth in this chapter, for the type of forensic
				  tests and examinations performed in the laboratory; and
B. Technical reviews of case files and
				  reports are conducted as determined by the Director or applicable
				  standards.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 51 - FORENSIC LABORATORIES › Chapter 10.51.06 - Employees › Section 10.51.06.15 - Forensic Analysis Employees - Qualifications

Current through Register Vol. 51, No. 14, July 12, 2024
A. Forensic Analysis Employees -
				  Qualifications for Toxicology and Trace Evidence Disciplines.
(1) A forensic analyst working in toxicology
				  or trace evidence disciplines of a forensic laboratory shall:
(a) Possess a baccalaureate or advanced
				  degree in a natural science, forensic science, or a closely related field of
				  science; and
(b) Have successfully
				  completed a training program in forensic toxicology or forensic analysis of
				  trace evidence, as determined by the laboratory director.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 51 - FORENSIC LABORATORIES › Chapter 10.51.06 - Employees › Section 10.51.06.16 - Forensic Analysis Employee Responsibilities - General

Current through Register Vol. 51, No. 14, July 12, 2024
A licensee shall ensure that:
A. A forensic analysis employee is
				  responsible for:
(1) Specimen and sample
				  processing;
(2) Performing forensic
				  analyses; and
(3) Reporting
				  forensic analysis results; and
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 51 - FORENSIC LABORATORIES › Chapter 10.51.06 - Employees › Section 10.51.06.17 - Forensic Analysis Employee Responsibilities - Specific

Current through Register Vol. 51, No. 14, July 12, 2024
Regardless of the forensic analysis category, an individual
					 who performs a forensic analysis shall:
A. Follow the forensic laboratory's approved
				  procedures for:
(1) Specimen and sample
				  handling and processing;
(2)
				  Performing the forensic analysis; and
(3) Reporting and maintaining records of
				  forensic analysis results;
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 51 - FORENSIC LABORATORIES › Chapter 10.51.07 - Sanctions › Section 10.51.07.01 - Sanctions - General

Current through Register Vol. 51, No. 14, July 12, 2024
A.
				  Authority and Types.
(1) The Secretary may
				  impose one or more principal or alternative sanctions if a forensic laboratory
				  or the laboratory's director or other employees fail to meet the standards of
				  this subtitle and Health"General Article, Title 17, Subtitle 2A, Annotated Code
				  of Maryland.
(2) Principal
				  Sanctions. The Secretary may impose the following principal sanctions:
(a) Denial of a license;
(b) Suspension of a license; or
(c) Revocation of a license.
(3) Alternative Sanctions. Instead
				  of or in conjunction with withdrawing a principal sanction, the Secretary may
				  impose one or more of the following alternative sanctions:
(a) A directed plan of correction;
(b) Limitation on forensic analyses;
				  or
(c) Training and technical
				  assistance.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 51 - FORENSIC LABORATORIES › Chapter 10.51.07 - Sanctions › Section 10.51.07.02 - Sanctions - Departmental Actions

Current through Register Vol. 51, No. 14, July 12, 2024
A. Deficiency Posing Immediate Jeopardy.
(1) If a forensic laboratory's deficiency
				  poses immediate jeopardy to public safety or individual rights, the Secretary
				  shall take one or more of the actions listed in §A(2) and (3) of this
				  regulation.
(2) Initial Actions.
				  When a deficiency involving immediate jeopardy is first identified, the
				  Secretary shall:
(a) Require the forensic
				  laboratory to take immediate action to remove the jeopardy; and
(b) Impose:
(i) A principal sanction after giving the
				  forensic laboratory at least 24 hours' notice; or
(ii) One or more alternative
				  sanctions.
(3) Follow-up Actions. If the Department
				  finds, in a follow-up audit of a forensic laboratory under an alternative
				  sanction, that the forensic laboratory has not eliminated the immediate
				  jeopardy, the Secretary shall impose a principal sanction after giving the
				  forensic laboratory at least 24 hours' notice.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 51 - FORENSIC LABORATORIES › Chapter 10.51.07 - Sanctions › Section 10.51.07.03 - Principal Sanctions - Departmental Actions

Current through Register Vol. 51, No. 14, July 12, 2024
A. Hearing Requirement.
(1) Except when the Secretary finds that a
				  danger to public safety imperatively requires that emergency action be taken to
				  correct a deficiency, the Secretary shall inform the licensee in writing:
(a) If a suspension or revocation of the
				  licensee's license takes effect;
(b) The reason for the suspension or
				  revocation; and
(c) That the
				  licensee has an opportunity for a hearing on the matter before the suspension
				  or revocation takes effect, as provided in State Government Article, §
												10-226, Annotated
				  Code of Maryland.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 51 - FORENSIC LABORATORIES › Chapter 10.51.07 - Sanctions › Section 10.51.07.04 - Enforcement Procedures - Proficiency Testing

Current through Register Vol. 51, No. 14, July 12, 2024
A. Application. If a forensic laboratory's
				  performance in proficiency testing is unsatisfactory, as set forth in this
				  subtitle, the Secretary may require the forensic laboratory to undertake the
				  directed plan of correction of training the forensic laboratory employees or
				  obtaining technical assistance, or both, in order to meet the proficiency
				  testing requirements of this subtitle.
B. Procedures. A forensic laboratory required
				  to undertake training of employees or to obtain necessary technical assistance
				  shall:
(1) Document the training or
				  assistance, or both, using a form provided by the Department; and
(2) Submit the completed form to the
				  Department.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 51 - FORENSIC LABORATORIES › Chapter 10.51.07 - Sanctions › Section 10.51.07.05 - Departmental Action - Reporting Erroneous Test Results

Current through Register Vol. 51, No. 14, July 12, 2024
A. If the Department determines that a
				  licensee has reported an erroneous test result that threatens the safety or
				  rights of an individual, the Secretary may order the licensee, within a
				  specified period of time, to:
(1) Give prompt
				  notice of the erroneous test result to:
(a)
				  The person who ordered the forensic analysis be performed;
(b) Any other person to whom the forensic
				  laboratory has previously sent a report that contained the erroneous test
				  result;
(c) The Office of Public
				  Defender or counsel of record; and
(d) The State's Attorney;
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 52 - PREVENTIVE MEDICINE › Chapter 10.52.01 - Opioid-Associated Disease Prevention and Outreach (OADPO) Programs › Section 10.52.01.01 - Purpose and Scope

Current through Register Vol. 51, No. 14, July 12, 2024
This chapter:
A.
				  Defines an opioid-associated disease prevention and outreach program;
				  and
B. Sets forth:
(1) The responsibilities of the Department of
				  Health and Mental Hygiene and local health departments in establishing
				  opioid-associated disease prevention and outreach programs; and
(2) Requirements for:
(a) Monitoring and evaluating
				  opioid-associated disease prevention and outreach programs; and
(b) Research conducted in collaboration with
				  an opioid-associated disease prevention and outreach program.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 52 - PREVENTIVE MEDICINE › Chapter 10.52.01 - Opioid-Associated Disease Prevention and Outreach (OADPO) Programs › Section 10.52.01.02 - Definitions

Current through Register Vol. 51, No. 14, July 12, 2024
A. In this chapter,
				  the following terms have the meaning indicated.
B. Terms Defined.
(1) 'Applicant" means a local health
				  department or community-based organization seeking to establish an
				  opioid-associated disease prevention and outreach program.
(2) Body Fluid.
(a) "Body fluid" means any fluid containing
				  visible blood, semen, or vaginal secretions.
(b) "Body fluid" does not include
				  cerebrospinal fluid, synovial fluid, breast milk, amniotic fluid, saliva,
				  stool, nasal secretions, sputum, tears, urine, orvomitus.
(3) "Community-based organization (CBO) "
				  means a public or private organization that:
(a) Is representative of a community or
				  significant segments of a community; and
(b) Provides educational, health, or social
				  services to individuals in the community.
(4) "Department" means the Department of
				  Health and Mental Hygiene.
(5)
				  "Harm reduction education " means education on practical strategies:
(a) To reduce negative consequences
				  associated with drug use; and
(b)
				  That reflect specific individual and community needs.
(6) "HIV" means the human immunodeficiency
				  virus that causes acquired immune deficiency syndrome (AIDS).
(7) "Infection control" means infection
				  prevention and control measures that ensure the protection of individuals who
				  are vulnerable to acquiring an infection both in the general community and
				  while receiving health care services in a range of settings.
(8) "Injection supplies " means materials
				  used to inject drugs including, but not limited to:
(a) Cookers;
(b) Water; and
(c) Cotton.
(9) "Naloxone" means an opioid antagonist
				  indicated for the emergency treatment of known or suspected opioid overdose, as
				  manifested by respiratory or central nervous system depression.
(10) "OADPO program" means an
				  opioid-associated disease prevention and outreach program established by a
				  local health department or community-based organization that provides services
				  including:
(a) Dissemination of hypodermic
				  needles or syringes and other preventive means for curtailing the spread of HIV
				  and viral hepatitis;
(b) Overdose
				  prevention education; and
(c) Harm
				  reduction education.
(11) "Participant" means an individual who
				  has registered with an OADPO program.
(12) "Sexually transmitted infection (STI) "
				  means an infection passed from one person to another person through sexual
				  contact.
(13) "Viral hepatitis"
				  means inflammation of the liver caused by the hepatitis A, B, C, D, and E
				  viruses.
(14) "Wound care" means
				  treatment of the symptoms of infections that may result from using
				  drugs.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 52 - PREVENTIVE MEDICINE › Chapter 10.52.01 - Opioid-Associated Disease Prevention and Outreach (OADPO) Programs › Section 10.52.01.03 - Program Establishment

Current through Register Vol. 51, No. 14, July 12, 2024
A.
				  Effective October 1, 2016, a local health department or CBO may establish an
				  OADPO program with approval from the:
(1)
				  Department; and
(2) Local health
				  officer of the county in which OADPO program operations are proposed.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 52 - PREVENTIVE MEDICINE › Chapter 10.52.01 - Opioid-Associated Disease Prevention and Outreach (OADPO) Programs › Section 10.52.01.04 - Application Process

Current through Register Vol. 51, No. 14, July 12, 2024
A. An
				  applicant:
(1) Shall submit an application to
				  establish an OADPO program to the Department that includes:
(a) Responses to all applicable questions;
				  and
(b) Any supporting
				  documentation indicated on the application;
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 52 - PREVENTIVE MEDICINE › Chapter 10.52.01 - Opioid-Associated Disease Prevention and Outreach (OADPO) Programs › Section 10.52.01.05 - Program Design and Operation

Current through Register Vol. 51, No. 14, July 12, 2024
A. The CBO or local health department
				  approved to operate an OADPO program:
(1)
				  Shall provide protocols for the safety and security of OADPO program locations,
				  equipment, and staff in accordance with Regulation .06 of this chapter that:
(a) Control the dissemination of hypodermic
				  needles and syringes; and
(b) Allow
				  for a full accounting of the number of hypodermic needles and syringes managed
				  by the program;
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 52 - PREVENTIVE MEDICINE › Chapter 10.52.01 - Opioid-Associated Disease Prevention and Outreach (OADPO) Programs › Section 10.52.01.06 - Program Security

Current through Register Vol. 51, No. 14, July 12, 2024
A. An
				  OADPO program shall implement protocols for the safety and security of program
				  locations, equipment, and staff.
B.
				  OADPO program staff shall:
(1) Wear suitable
				  clothing, including closed footwear, at all times;
(2) Treat all body fluids as potentially
				  infectious and follow infection control protocols at all times including:
(a) Use of barriers including
				  gloves;
(b) Immediate washing of
				  hands and other skin surfaces after contact with body fluids; and
(c) Careful handling and disposal of sharp
				  instruments during and after use;
(3) When working off-site, have access to a
				  communications system that allows staff to stay in contact with:
(a) Other staff; and
(b) Emergency support;
(4) Obtain consent of the owner or occupier
				  of private property to enter the property to dispense or collect syringes or
				  hypodermic needles; and
(5)
				  Transport biohazardous waste to the disposal facility using a method that does
				  not put any individuals at risk.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 52 - PREVENTIVE MEDICINE › Chapter 10.52.01 - Opioid-Associated Disease Prevention and Outreach (OADPO) Programs › Section 10.52.01.07 - Monitoring and Evaluation

Current through Register Vol. 51, No. 14, July 12, 2024
A.
				  OADPO programs shall:
(1) Submit all data for
				  each reporting period on a quarterly basis as required by the Department,
				  including:
(a) The number of:
(i) Participants served by the OADPO
				  program;
(ii) New participants
				  registered by the OADPO program;
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 52 - PREVENTIVE MEDICINE › Chapter 10.52.01 - Opioid-Associated Disease Prevention and Outreach (OADPO) Programs › Section 10.52.01.08 - Research

Current through Register Vol. 51, No. 14, July 12, 2024
A. An individual
				  researcher or institution shall apply for and receive approval from the
				  Department before starting research in collaboration with an OADPO
				  program.
B. The Department shall:
(1) Review each request; and
(2) Approve or disapprove the proposed
				  research based on whether the proposed research:
(a) Advances scientific knowledge or practice
				  related to opioid-associated disease prevention and outreach;
(b) Has approaches, aims, and methods that
				  will allow the researcher to perform descriptive analyses or test
				  hypotheses;
(c) Has one or more
				  investigators who have training and experience with the approaches and
				  methods;
(d) Will impede or
				  interfere with the operations of the OADPO program;
(e) Is approved by the Department's
				  Institutional Review Board to ensure that the research will be conducted
				  according to established ethical guidelines for research in the field of
				  opioid-associated disease prevention and outreach; and
(f) Will keep any data used for the research
				  confidential as required by:
(i)
				  Health-General Article, §24-906(B), Annotated Code of Maryland;
(ii)
													42 U.S.C. §
														290dd-2; and
(iii) 42 CFR Part 2.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 52 - PREVENTIVE MEDICINE › Chapter 10.52.01 - Opioid-Associated Disease Prevention and Outreach (OADPO) Programs › Section 10.52.01.09 - Revocation of Approval and Appeals

Current through Register Vol. 51, No. 14, July 12, 2024
A. The Department and the local health
				  officer may revoke the approval of an OADPO program if the OADPO program does
				  not:
(1) Meet the requirements of
				  Health-General Article, Title 24, Subtitle 9, Annotated Code of Maryland;
				  or
(2) Operate in accordance with
				  the requirements of Regulations .05 and .06 of this chapter.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 52 - PREVENTIVE MEDICINE › Chapter 10.52.03 - Health Education-General Regulations › Section 10.52.03.01 - Health Education Services Regulations

Current through Register Vol. 51, No. 14, July 12, 2024
A. Type of Service to Be Provided. Services
				  to be provided are health education services of a general nature for purposes
				  of informing the public about various health issues, promoting health enhancing
				  behaviors, and organizing groups to promote the health enhancing activities of
				  others or to achieve societal and environmental changes conducive to health.
				  These services include but are not limited to the following:
(1) Planning, conducting, and evaluating a
				  media campaign or a component of a media campaign;
(2) Planning, conducting, and evaluating an
				  employee or community intervention for a specified behavior change;
(3) Training health professionals to provide
				  effective education to their clients;
(4) Distributing existing or newly developed
				  health-related educational materials and resources;
(5) Organizing and leading a group to find
				  goals and strategies to achieve a health end;
(6) Implementing population-based health
				  education programs using evidence-based methods and strategies;
(7) Assessing and analyzing community needs
				  and assets;
(8) Accessing,
				  interpreting, and disseminating qualitative and quantitative data;
				  and
(9) Planning, conducting, and
				  evaluating health promotion and education interventions and
				  initiatives.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 52 - PREVENTIVE MEDICINE › Chapter 10.52.04 - Condom Vending Machines › Section 10.52.04.01 - Scope

Current through Register Vol. 51, No. 14, July 12, 2024
A. This chapter
				  applies to a condom offered for sale or sold by means of a vending machine or
				  other automatic device, and to a vending machine or other automatic device used
				  for selling condoms.
B. This
				  chapter does not apply to a condom sold person-to-person in a business
				  establishment.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 52 - PREVENTIVE MEDICINE › Chapter 10.52.04 - Condom Vending Machines › Section 10.52.04.02 - Approved Condoms

Current through Register Vol. 51, No. 14, July 12, 2024
A condom that is approved by the U.S. Food and Drug
					 Administration (FDA) as a medical device may be sold or offered for sale by
					 means of a vending machine or other automatic device.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 52 - PREVENTIVE MEDICINE › Chapter 10.52.04 - Condom Vending Machines › Section 10.52.04.03 - Labeling of Product

Current through Register Vol. 51, No. 14, July 12, 2024
A novelty device which resembles a condom but is not
					 intended for prevention of sexually transmitted diseases or pregnancy and is
					 not FDA approved as a medical device shall be clearly marked: "This item is not
					 intended for prevention of sexually transmitted diseases or
					 pregnancy."
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 52 - PREVENTIVE MEDICINE › Chapter 10.52.04 - Condom Vending Machines › Section 10.52.04.04 - Labeling of Vending Machine

Current through Register Vol. 51, No. 14, July 12, 2024
A vending machine or other automatic device used for
					 selling condoms shall be labeled with the name, address, and telephone number
					 of the person or firm responsible for stocking the machine with
					 condoms.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 52 - PREVENTIVE MEDICINE › Chapter 10.52.05 - Pertussis and Pertussis Vaccine › Section 10.52.05.01 - Definitions

Current through Register Vol. 51, No. 14, July 12, 2024
A. "Department"
				  means the Maryland Department of Health and Mental Hygiene.
B. "Health care provider" means any licensed
				  health care professional, organization, or institution, whether public or
				  private, under whose authority pertussis vaccine is administered.
C. "Major adverse reaction" means any:
(1) Serious illness, disability, or
				  impairment of mental, emotional, behavioral, or physical functioning or
				  development, the first manifestation of which appears within 7 days after the
				  date of administration of pertussis vaccine and for which there is reasonable
				  scientific or medical evidence pertussis vaccine causes, or significantly
				  contributes to, the effect; and
(2)
				  Other reaction which the Department, after consultation with the Medical and
				  Chirurgical Faculty of Maryland, determines is a basis for not continuing with
				  pertussis vaccine administration.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 52 - PREVENTIVE MEDICINE › Chapter 10.52.05 - Pertussis and Pertussis Vaccine › Section 10.52.05.02 - Requirements for Health Care Providers

Current through Register Vol. 51, No. 14, July 12, 2024
A. Before the administration of pertussis
				  vaccine, the health care provider shall provide to the patient's parent or
				  guardian written information addressing:
(1)
				  The frequency, severity, and potential long-term effects of
				  pertussis;
(2) Possible adverse
				  reactions to pertussis vaccine, which, if they occur, should be brought to the
				  immediate attention of the health care provider;
(3) A form that lists symptoms of possible
				  pertussis vaccine adverse reactions to be monitored and which contains places
				  where information can be recorded to assist in reporting to the health care
				  provider, local health officer, and the Department;
(4) Measures parents should take to reduce
				  the risk of, or to respond to, any major adverse reaction to pertussis
				  vaccine;
(5) Early warning signs or
				  symptoms to which parents should be alert as possible precursors to a major
				  adverse reaction to pertussis vaccine;
(6) When and to whom parents should report
				  any major adverse reactions to pertussis vaccine;
(7) A summary of the immunization
				  requirements adopted under Education Article, §
											7-402(a),
				  Annotated Code of Maryland, including those related to pertussis
				  vaccine;
(8) The circumstances
				  under which pertussis vaccine may not be administered;
(9) The circumstances under which
				  administration of pertussis vaccine shall be delayed; and
(10) Categories of potential recipients who
				  are significantly more vulnerable to major adverse reactions to pertussis
				  vaccine than is the general population.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 52 - PREVENTIVE MEDICINE › Chapter 10.52.05 - Pertussis and Pertussis Vaccine › Section 10.52.05.03 - Requirements of Local Health Officers

Current through Register Vol. 51, No. 14, July 12, 2024
A. Upon receipt of notification of a major
				  adverse reaction to a pertussis vaccine, the local health officer shall:
(1) Notify and forward the morbidity report
				  card to the Department within 24 hours; and
(2) Assure that the necessary information to
				  fill out a "Report of Adverse Event Following Immunization" is
				  obtained.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 52 - PREVENTIVE MEDICINE › Chapter 10.52.05 - Pertussis and Pertussis Vaccine › Section 10.52.05.04 - Requirements of the Department

Current through Register Vol. 51, No. 14, July 12, 2024
A.
				  Whenever a resident birth occurs, the Department shall promptly provide parents
				  of the newborn child with information included in Regulation .02A(1)-(10) of
				  this chapter.
B. The Department
				  shall prescribe the form and content of the information about immunizations
				  provided to parents at times of birth and of administration of pertussis
				  vaccine, according to Regulation .02A(1)-(10) of this chapter.
C. Upon receipt of information regarding a
				  major adverse reaction to a pertussis vaccine, the Department shall immediately
				  notify the vaccine manufacturer of the following:
(1) Date of immunization;
(2) Lot number of vaccine; and
(3) Type of reaction.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 52 - PREVENTIVE MEDICINE › Chapter 10.52.05 - Pertussis and Pertussis Vaccine › Section 10.52.05.05 - General

Current through Register Vol. 51, No. 14, July 12, 2024
Nothing in these regulations shall be construed to affect
					 any emergency authority of the Secretary of Health and Mental Hygiene under any
					 other provision of law to protect the public health.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 52 - PREVENTIVE MEDICINE › Chapter 10.52.06 - Use of Tanning Devices by Minors › Section 10.52.06.01 - Scope

Current through Register Vol. 51, No. 14, July 12, 2024
A. This chapter
				  establishes regulations on the use of tanning devices by minors.
B. Nothing in this chapter preempts a county
				  or municipal government from enacting and enforcing more stringent measures to
				  regulate the use of tanning devices by minors.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 52 - PREVENTIVE MEDICINE › Chapter 10.52.06 - Use of Tanning Devices by Minors › Section 10.52.06.02 - Definitions

Current through Register Vol. 51, No. 14, July 12, 2024
A. In this chapter,
				  the following terms have the meanings indicated.
B. Terms Defined.
(1) "Customer" means a member of the public
				  who is provided access to a tanning device in exchange for a fee, membership
				  dues, or other compensation.
(2)
				  "Department" means the Maryland Department of Health and Mental
				  Hygiene.
(3) "Health officer" means
				  the health officer of each of the 23 counties in Maryland and the Commissioner
				  of Health in Baltimore City, the duly designated representative of the health
				  officer, or both.
(4) "Minor" means
				  an individual younger than 18 years old.
(5) "Owner" means an individual or entity
				  having an ownership interest in a tanning facility.
(6) "Person-in-charge" means an owner,
				  operator, manager, employee, or other individual who controls, governs, or
				  directs the activities of a tanning facility and is present on site.
(7) "Phototherapy device" means any equipment
				  that emits ultraviolet radiation and is used in the diagnosis or treatment of
				  disease or injury.
(8) "Radiation"
				  means ultraviolet radiation.
(9)
				  "Secretary" means the Secretary of Health and Mental Hygiene or the Secretary's
				  designee.
(10) "Tanning device"
				  means any equipment that emits radiation used for tanning of the skin,
				  including sunlamps, tanning booths, or tanning beds.
(11) "Tanning facility" means any place where
				  a tanning device is used for a fee, membership dues, or other
				  compensation.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 52 - PREVENTIVE MEDICINE › Chapter 10.52.06 - Use of Tanning Devices by Minors › Section 10.52.06.03 - Exclusions

Current through Register Vol. 51, No. 14, July 12, 2024
This chapter does not apply to the use of any phototherapy
					 device by a health care practitioner acting within the scope of the license of
					 the health care practitioner or by order of a health care practitioner acting
					 within the scope of the license of the health care practitioner.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 52 - PREVENTIVE MEDICINE › Chapter 10.52.06 - Use of Tanning Devices by Minors › Section 10.52.06.04 - Verification of Age

Current through Register Vol. 51, No. 14, July 12, 2024
A person-in-charge may not allow a customer to use a
					 tanning device at a tanning facility without confirmation, with a State or
					 federal government-issued identification card, that the individual is not a
					 minor.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 52 - PREVENTIVE MEDICINE › Chapter 10.52.06 - Use of Tanning Devices by Minors › Section 10.52.06.05 - Posting of Notices

Current through Register Vol. 51, No. 14, July 12, 2024
A. A
				  tanning facility shall display conspicuously a notice that conforms to the
				  requirements of §B of this regulation.
B. The notice shall state:
(1) That it is unlawful for a tanning
				  facility owner, employee, or operator to allow a minor to use any tanning
				  device;
(2) That a tanning facility
				  owner, employee, or operator that violates one or more provisions of this
				  section may be subject to a civil penalty;
(3) The health risks associated with tanning,
				  including skin cancer, premature skin aging, injuries including burns, and
				  adverse reactions when combined with certain medications, foods, and cosmetics;
				  and
(4) That an individual may
				  report a violation of one or more provisions of this chapter to the local law
				  enforcement agency or local health department.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 52 - PREVENTIVE MEDICINE › Chapter 10.52.06 - Use of Tanning Devices by Minors › Section 10.52.06.06 - Complaints and Investigations

Current through Register Vol. 51, No. 14, July 12, 2024
A.
				  A person or law enforcement officer may report a violation of this chapter to
				  the health officer in the jurisdiction where the alleged violation took
				  place.
B. The Department shall make
				  available a complaint form at the Department's website and at a local health
				  department.
C. Upon receipt of a
				  complaint, the health officer shall investigate the
				  complaint.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 52 - PREVENTIVE MEDICINE › Chapter 10.52.06 - Use of Tanning Devices by Minors › Section 10.52.06.07 - Enforcement

Current through Register Vol. 51, No. 14, July 12, 2024
A. A health officer
				  may investigate conditions relative to the enforcement of this
				  chapter.
B. The person-in-charge of
				  a tanning facility shall permit a health officer to enter the tanning facility
				  during business hours for the purpose of determining compliance with this
				  chapter.
C. If an investigation is
				  made, the health officer shall:
(1) Document:
(a) The result of the investigation on a
				  report form provided by the Department; and
(b) A condition found that is in violation of
				  a provision of this chapter;
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 52 - PREVENTIVE MEDICINE › Chapter 10.52.06 - Use of Tanning Devices by Minors › Section 10.52.06.08 - Violations and Certification of Correction

Current through Register Vol. 51, No. 14, July 12, 2024
A. The health officer shall provide the owner
				  of a tanning facility found in violation of a provision of this chapter or
				  Health-General Article, § 20-106, Annotated Code of Maryland, with a
				  written notice that contains:
(1) The
				  specific finding and, if applicable, the penalty for the violation, as set
				  forth in Regulation .09 of this chapter;
(2) A specific date by which the owner shall
				  correct the violation;
(3) A
				  provision that, if the owner fails to correct the violation by the date
				  specified or is in violation of another provision of Health-General Article,
				  § 20-106, Annotated Code of Maryland, at another time, the Secretary may
				  impose a subsequent penalty, if applicable, as set forth in Regulation .09 of
				  this chapter; and
(4) A provision
				  that the owner is entitled to request a hearing under Regulation .10 of this
				  chapter on a violation with a penalty.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 52 - PREVENTIVE MEDICINE › Chapter 10.52.06 - Use of Tanning Devices by Minors › Section 10.52.06.09 - Penalties

Current through Register Vol. 51, No. 14, July 12, 2024
The penalties for a violation of Regulation .04 or .05 of
					 this chapter, or of Health-General Article, § 20-106, Annotated Code of
					 Maryland, are:
A. A letter of
				  reprimand for the first violation;
B. A civil penalty of $250 for a second
				  violation;
C. A civil penalty of
				  $500 for a third violation; and
D.
				  A civil penalty of $1,000 for each subsequent violation.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 52 - PREVENTIVE MEDICINE › Chapter 10.52.06 - Use of Tanning Devices by Minors › Section 10.52.06.10 - Request for Hearing

Current through Register Vol. 51, No. 14, July 12, 2024
A. A
				  person who receives a notice of violation with a penalty for a violation of
				  Regulation .04 or .05 of this chapter, or of Health-General Article, §
				  20-106, Annotated Code of Maryland, may request a hearing on the notice of
				  violation with a penalty.
B. In
				  order to preserve a right to a hearing on a violation with a penalty under this
				  chapter, if a hearing is desired, a person shall submit a written request to
				  the Department's Environmental Health Bureau under the Prevention and Health
				  Promotion Administration for a hearing within 10 days of receipt of the notice
				  of violation with a penalty.
C. In
				  accordance with the Administrative Procedure Act, State Government Article,
				  Title 10, Subtitle 2, Annotated Code of Maryland, the Secretary shall provide
				  for a hearing on the violation with a penalty by referring the matter to the
				  Office of Administrative Hearings.
D. The Office of Administrative Hearings
				  shall:
(1) Schedule and conduct the hearing on
				  the violation with a penalty; and
(2) Render a decision and notify the parties
				  of the decision within 90 days after the hearing.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 52 - PREVENTIVE MEDICINE › Chapter 10.52.07 - State Advisory Council on Health and Wellness › Section 10.52.07.01 - Definitions

Current through Register Vol. 51, No. 14, July 12, 2024
A. In this chapter,
				  the following terms have the meanings indicated.
B. Terms Defined.
(1) "Chronic disease" means a noncommunicable
				  condition that is a major cause of sickness or disability, including, but not
				  limited to:
(a) Heart disease;
(b) Cancer;
(c) Arthritis; and
(d) Diabetes.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 52 - PREVENTIVE MEDICINE › Chapter 10.52.07 - State Advisory Council on Health and Wellness › Section 10.52.07.02 - Membership

Current through Register Vol. 51, No. 14, July 12, 2024
A. The Council
				  shall consist of 34 members appointed by the Secretary according to
				  Health-General Article, §13-203, Annotated Code of Maryland.
B. A member shall:
(1) Be a Maryland resident; or
(2) If a qualified Maryland resident is not
				  available to be appointed to a Council position, possess special knowledge or
				  training required for the Council position to which they are
				  appointed.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 52 - PREVENTIVE MEDICINE › Chapter 10.52.07 - State Advisory Council on Health and Wellness › Section 10.52.07.03 - Committees

Current through Register Vol. 51, No. 14, July 12, 2024
A. The Council
				  shall have the following four committees:
(1)
				  Arthritis;
(2) Diabetes;
(3) Heart Disease and Stroke; and
(4) Physical Fitness.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 52 - PREVENTIVE MEDICINE › Chapter 10.52.07 - State Advisory Council on Health and Wellness › Section 10.52.07.04 - Council Duties

Current through Register Vol. 51, No. 14, July 12, 2024
A. The Council
				  shall:
(1) Provide guidance to the Secretary
				  on Statewide chronic disease prevention and control;
(2) Direct the priorities and work of the
				  committees; and
(3) Promote
				  evidence-based programs for:
(a) Healthy
				  lifestyles; and
(b) The prevention,
				  early detection, and treatment of chronic disease.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 52 - PREVENTIVE MEDICINE › Chapter 10.52.07 - State Advisory Council on Health and Wellness › Section 10.52.07.05 - Meetings and Procedures

Current through Register Vol. 51, No. 14, July 12, 2024
A. Meeting
				  Frequency.
(1) The Council shall meet at
				  least two times per year.
(2) A
				  committee created by Regulation .03A of this chapter shall meet at least four
				  times per year.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 52 - PREVENTIVE MEDICINE › Chapter 10.52.08 - Maryland HIV Prevention Case Management Program › Section 10.52.08.01 - Purpose and Scope

Current through Register Vol. 51, No. 14, July 12, 2024
This chapter:
A.
				  Defines the Maryland AIDS Drug Assistance Program Fund;
B. Sets forth the responsibilities of the
				  Maryland Department of Health with respect to the Maryland AIDS Drug Assistance
				  Program Fund; and
C. Establishes
				  eligibility criteria for receipt of HIV prevention and care services from the
				  Fund.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 52 - PREVENTIVE MEDICINE › Chapter 10.52.08 - Maryland HIV Prevention Case Management Program › Section 10.52.08.02 - Definitions

Current through Register Vol. 51, No. 14, July 12, 2024
A. In this
				  chapter, the following terms have the meanings indicated.
B. Terms Defined.
(1) "Acquired immunodeficiency syndrome
				  (AIDS)" means the medical condition caused by the human immunodeficiency
				  virus.
(2) "Department" means the
				  Maryland Department of Health.
(3)
				  "Fund" means the Maryland AIDS Assistance Program Fund.
(4) "Human immunodeficiency virus (HIV)"
				  means the virus that causes AIDS.
(5) "Ryan White HIV/AIDS Program (RWHAP)"
				  means the federal HIV/AIDS initiative administered by the U.S. Department of
				  Health and Human Services (HHS), Health Resources and Services Administration
				  (HRSA), HIV/AIDS Bureau (HAB).
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 52 - PREVENTIVE MEDICINE › Chapter 10.52.08 - Maryland HIV Prevention Case Management Program › Section 10.52.08.03 - Maryland AIDS Drug Assistance Program Fund

Current through Register Vol. 51, No. 14, July 12, 2024
A. The Maryland
				  AIDS Drug Assistance Program Fund is a nonlapsing, special fund created by
				  Health-General Article, §24-1801, Annotated Code of Maryland, for HIV
				  treatment and care, which is generated from:
(1) The 340B Drug Pricing Program and any
				  supplemental rebate dollars; and
(2) Interest earned on the balance of the
				  Fund.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 52 - PREVENTIVE MEDICINE › Chapter 10.52.08 - Maryland HIV Prevention Case Management Program › Section 10.52.08.04 - Responsibilities of the Department

Current through Register Vol. 51, No. 14, July 12, 2024
The Department:
A.
				  Shall administer the Fund; and
B.
				  May spend the Fund on statutorily permitted purposes under the RWHAP or
				  State-identified HIV priorities.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 52 - PREVENTIVE MEDICINE › Chapter 10.52.08 - Maryland HIV Prevention Case Management Program › Section 10.52.08.05 - Eligibility Criteria

Current through Register Vol. 51, No. 14, July 12, 2024
A. The Fund
				  shall be the reasonable payor of last resort for receipt of HIV prevention and
				  care services; and
B. Eligible
				  individuals shall have exhausted all other potential payors, including but not
				  limited to:
(1) Third-party
				  insurance;
(2) Medicaid;
				  and
(3) Medicare.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 52 - PREVENTIVE MEDICINE › Chapter 10.52.10 - HIV and Hepatitis C Testing of Persons Accused or Convicted, or Both, of Certain Crimes › Section 10.52.10.01 - Scope

Current through Register Vol. 51, No. 14, July 12, 2024
This chapter establishes procedures for HIV and hepatitis C
					 testing ordered under the provisions of Criminal Procedure Article,
					 §§ 11-107-11 -117, Annotated Code of Maryland.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 52 - PREVENTIVE MEDICINE › Chapter 10.52.10 - HIV and Hepatitis C Testing of Persons Accused or Convicted, or Both, of Certain Crimes › Section 10.52.10.03 - Notice

Current through Register Vol. 51, No. 14, July 12, 2024
A. The
				   health officer shall require
				  receipt of a written notice and a copy of a court order for testing from a
				  State's Attorney before initiating the process of HIV or hepatitis C testing
				  and notification described in this chapter.
B. The State's Attorney shall include all of
				  the following in the written notice:
(1) The
				  name of the offender to be tested;
(2) The address of the offender's
				  residence;
(3) The name of the
				  victim who has requested information; and
(4) The address of the victim's
				  residence.